Consulting Case Interview by Bain Associate Consultant

For more Career and MBA related content, follow: @ZiadShares
In this video, Rhea (a current Bain Associate Consultant) goes through a full Case interview. The question involves both a market entry and market sizing situation. We go through all parts of the case here from:
1) Introduction and Prompt
2) Framework
3) Analysis (Sizing + Brainstorming)
4) Conclusion

Пікірлер: 37

  • @MrMcfire2
    @MrMcfire29 ай бұрын

    Great content! Would be better without the background music imo

  • @turkiabdulaziz8207
    @turkiabdulaziz8207 Жыл бұрын

    she did amazing job! well structured and clear thoughts.

  • @tourdeNoh
    @tourdeNoh5 ай бұрын

    she's so eloquent!

  • @ennagadali3483
    @ennagadali34835 ай бұрын

    She did a great job 😊

  • @datascientist6233
    @datascientist623316 күн бұрын

    Excellent...

  • @atharva__shukla
    @atharva__shukla9 ай бұрын

    I think a company that's expecting an FDA approval (and has gone through all the troubles associated with that) has already made up their mind about getting into the said market 🤷‍♂ Correct me if I'm wrong

  • @qazcom0

    @qazcom0

    6 ай бұрын

    Same thought here!

  • @TheDestint

    @TheDestint

    28 күн бұрын

    Trouble + huge investment of time , $$, and resources.

  • @joshuaprasad5521
    @joshuaprasad5521Ай бұрын

    Why this guy a lil too serious tho

  • @xander1201
    @xander120110 ай бұрын

    How much time are you actually entitled to get when thinking of a solution to a case?

  • @giuseppe.manzone

    @giuseppe.manzone

    4 ай бұрын

    You should count no more than 60-90 seconds to lay down your structure, you can gain 60 more seconds if you’re completely able to discuss with your interviewer while you’re writing it down

  • @counterpoint9260

    @counterpoint9260

    2 ай бұрын

    you get 120 secs if you are lookin hot

  • @shm6854
    @shm68549 ай бұрын

    ❤cool

  • @irsmohsen4833
    @irsmohsen483311 ай бұрын

    5:01 She says she's going to estimate the Botox injections market.. I thought we are studying the migraine market

  • @1Piece_Luffy

    @1Piece_Luffy

    11 ай бұрын

    I know what you are saying. Unlike her, you, who are not familiar with the medical lexicon, should ask additional clarifying questions upfront. Migraine is essentially a severe headache. Botulinum Toxin (BoTox) is both the name of the wrinkle-removing toxin and the name of the company. So she is right that the objective of this case is to estimate the BoTox injections market geared toward resolving migraine. It may be a surprise that this toxin is indeed used to treat some severe headaches.

  • @ignaciovc3365

    @ignaciovc3365

    9 ай бұрын

    Did not get why she analysed the Botox market if the question was entering a new market..@@1Piece_Luffy

  • @gracema9480
    @gracema94802 ай бұрын

    Good but the figures are so off 😅

  • @LudwigVanHeinen

    @LudwigVanHeinen

    4 күн бұрын

    Consultant companies don't care about how accurate your numbers are, they do care about your thinking processes and logic. The main reason is that finding the market shares and else is readily available by googling them whereas having a good thinking process and logic cannot be googled.

  • @irsmohsen4833
    @irsmohsen4833 Жыл бұрын

    8:23 how come she assumes the company owns 30% of the market share if they have not joined the market yet?

  • @1Piece_Luffy

    @1Piece_Luffy

    11 ай бұрын

    Like my comment below, you should consider asking more clarifying questions upfront (Ex. "How are other firms treating migraine now? With other substances?"). Since Migraine is merely a disease (extreme headache), you can actually treat it with existing medicine you can find in CVS or Walgreens. Therefore, you should not assume that your client can enjoy 100% market share. She is saying that a 30% share is not too excessive because BoTox is a product line registered with a trademark by AbbVie, the 6th largest medical company in North America. Nevertheless, I think she went a tad aggressive. I would've picked 10% or 15% (at that moment, since I would've asked competitive landscape in the later bucket) since there are quite a number of giant medicine groups. But whenever the interviewer says OK, you are fine with whatever number you choose.

  • @jingjiezhou

    @jingjiezhou

    11 ай бұрын

    I think many of her assumptions are not that reasonable, sometimes maybe the interviewer only cares about the analyzing process but not the figures.

  • @ghg27689gf

    @ghg27689gf

    2 ай бұрын

    I think she assumes that the company could potentially get upto a 30% market share which is much on the higher side as the market is not growing and there are existing established competitors

  • @richboy3860
    @richboy38603 ай бұрын

    Her approach is awesome, but she uses ‘awesome’ too often

  • @AgreeWithKT
    @AgreeWithKT5 ай бұрын

    Where is the Top Down Approach?

  • @gdsarda24

    @gdsarda24

    3 ай бұрын

    She does talks about market size, competition, price elasticity, us population, people suffering from headaches, total no of patients, injections per patient. So isn’t that top down approach?

  • @HH-xs2gm
    @HH-xs2gm7 ай бұрын

    This is way harder than IB 💀

  • @LaVidaDelRoba

    @LaVidaDelRoba

    11 күн бұрын

    I agree haha

  • @DrishtiHarlalka
    @DrishtiHarlalka3 ай бұрын

    The number of times she says awesome, it’s very hard to focus on anything else in the beginning.

  • @profh9382
    @profh93823 ай бұрын

    Awesome😂, awesome😂, migraine market, awesome😂. Instant pass on hiring.

  • @roshniajm

    @roshniajm

    Ай бұрын

    It was so annoying

  • @Lottiya
    @LottiyaАй бұрын

    The music is so unnecessary… great otherwise :)

  • @samoh6084
    @samoh60844 ай бұрын

    oh my god the interviewer is so mean

  • @aditya12399
    @aditya1239921 күн бұрын

    What a fuckall approach. One clarifying question and she understood everything? Wtf

  • @fezz2945
    @fezz2945Ай бұрын

    Total crap… She forget a lot and made it school kid easy.. 1) Governance 2) Insurance 3) Age Groups 4) Patent on and old product, Patient renewal 5) Practice 6) Cheaper competitors 7) Phase 2 Testing All the things that matter and maybe more I forgot…

  • @joshuaprasad5521

    @joshuaprasad5521

    Ай бұрын

    I feel insurance companies should not have been overlooked